title: [Evaluation of guidance for blood sugar monitoring of schizophrenic patients while being medicated with the second generation anti-psychotic drugs. A cross-sectional study using base-line data].
authors.forename: Ichiro
authors.initials: I
authors.lastname: Kusumi
authors.forename: Koki
authors.initials: K
authors.lastname: Ito
authors.forename: Minoru
authors.initials: M
authors.lastname: Honda
authors.forename: Tadayuki
authors.initials: T
authors.lastname: Hayashishita
authors.forename: Keiichi
authors.initials: K
authors.lastname: Uemura
authors.forename: Naoki
authors.initials: N
authors.lastname: Hashimoto
authors.forename: Mitsukuni
authors.initials: M
authors.lastname: Murasaki
authors.forename: Yoshihito
authors.initials: Y
authors.lastname: Atsumi
authors.forename: Tadashi
authors.initials: T
authors.lastname: Kadowaki
authors.forename: Tsukasa
authors.initials: T
authors.lastname: Koyama
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D001786:Blood Glucose / Q000032:analysis*; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000592:standards; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D001786:Blood Glucose